Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yinhua Miyanjing Tablet for Type III Prostatitis
CTR20160209Phase 3Active
- Sponsor
- Jilin Huakang Pharmaceutical
- Start
- Aug 2016
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Yinhua Miyanjing Tablet in chronic prostatitis (CP), sponsored by Jilin Huakang Pharmaceutical. Started Aug 2016; status: active.
02
Drugs
Yinhua Miyanjing Tablet
03
Conditions
chronic prostatitis (CP)
Beyond the preview
Go deeper on CTR20160209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160209.